Methotrexate should be given with which of the following to decrease its side effects?
First, I recall that Methotrexate is a folate antagonist, used in rheumatoid arthritis and oncology. Its major side effect is myelosuppression and mucositis due to folate deficiency. The standard treatment to mitigate this is leucovorin (folinic acid), which is a reduced form of folate that doesn't get inhibited by Methotrexate. Leucovorin bypasses the blocked pathway, providing the necessary folate for normal cellular functions, especially in rapidly dividing cells.
Now, the options might include other drugs. For example, folic acid is sometimes used but not as effective as leucovorin because Methotrexate inhibits the conversion of folic acid to tetrahydrofolic acid. Other options could be things like dexamethasone (used in certain contexts but not for this), allopurinol (for hyperuricemia), or maybe something else. The key is that the correct answer is leucovorin, and the others are either not effective or used for different purposes.
I need to structure the explanation with the core concept being the use of leucovorin as a rescue agent. Then explain why leucovorin works, why folic acid is less effective, and why the other options are incorrect. The clinical pearl would be to remember that leucovorin is the rescue agent for Methotrexate toxicity.
**Core Concept** Methotrexate is a folic acid antagonist that inhibits dihydrofolate reductase, leading to folate deficiency. Leucovorin (folinic acid) is used as a rescue agent to bypass this block by directly supplying reduced folates for normal cellular metabolism.
**Why the Correct Answer is Right** Leucovorin is a reduced folate analog that does not require dihydrofolate reductase for activation. It provides essential tetrahydrofolate precursors, mitigating Methotrexate-induced myelosuppression, mucositis, and hepatotoxicity. This is critical in high-dose Methotrexate therapy for cancers or in autoimmune conditions requiring long-term use.
**Why Each Wrong Option is Incorrect**
**Option A:** *Dexamethasone* reduces inflammation but does not address Methotrexate’s folate antagonism.
**Option B:** *Folic acid* is ineffective because Methotrexate inhibits its conversion to active tetrahydrofolic acid.
**Option C:** *Allopurinol* prevents hyperuricemia from cell lysis but has no role in folate rescue.
**Clinical Pearl / High-Yield Fact** Remember: **"Leucovorin rescues the folate pathway blocked by Methotrexate."** Avoid folic acid supplementation in Methotrexate-treated patients, as it may reduce drug efficacy. Always check if the question refers to high-dose (requires leucovorin) vs. low-dose Methotrexate.
**Correct Answer: C. Leucovorin**